Heparin as a Therapy for Atherosclerosis: Preliminary Observations on the Intrapulmonary Administration of Low-Dose Heparin in the Morning Versus Evening Gauged by Its Effect on Blood Variables

Overview of attention for article published in Chronobiology International: The Journal of Biological & Medical Rhythm Research, July 2009

Altmetric Badge

Mentioned by

patent: 9 patents

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 9 patents that reference this research output.

Modified heparinase III and methods of sequencing therewith

Grant US-7939292-B2

United States of America

Methods and products related to pulmonary delivery of polysaccharides

Grant US-7709461-B2

United States of America

Rationally designed heparinases derived from heparinase I and II and methods of…

Grant US-7560106-B2

United States of America

Heparinase III and methods of specifically cleaving therewith

Grant US-7455986-B2

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 5 additional patents.